Cyberonics Seeks Coverage For Anti-Depression Implant In Select Patients

Cyberonics is pursuing national coverage of its VNS Therapy implant for treatment-resistant depression in a select group of patients, despite continued payor skepticism as to the technology's effectiveness

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight